Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, according to a study published in the Journal of Clinical Investigation.
This article was originally published on MedicalXpress.com
Enzyme PRMT5 found to drive chemotherapy resistance in ovarian cancer
You may also be interested in:
The Latest
Avoiding Common Relationship Mistakes for a Happier Love Life
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
The Latest
Why stress-related illness is so hard to diagnose, and how a patient-centred playful approach can help
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
Read More:
-
Researchers led by the Trondheim University Hospital in Norway report that two hours of immediate skin-to-skin contact between mothers and very preterm infants after birth [...]
-
Children with newly diagnosed celiac disease have increased arsenic exposure shortly after transitioning to a gluten-free diet, according to a study published in the April [...]
-
Medicaid unwinding disrupted kids’ and young adults’ access to chronic disease medicine, study finds
Children and young adults with depression, schizophrenia, ADHD, asthma and epilepsy can get great relief from medications to control their symptoms, helping them stay in [...]
